Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
153 |
|
Actual shortage: | 6 (4%) | |
Anticipated shortage: | 1 (1%) | |
Avoided shortage: | 5 (3%) | |
Resolved: | 141 (92%) | |
Discontinuation Reports |
51 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 51 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (14%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2022-03-16 | 2022-04-06 | 156780 |
TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2022-05-04 | 2022-08-05 | 159990 |
TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2022-08-29 | 2023-01-17 | 168148 |
TRAVATAN Z | 0.004% | SOLUTION | Actual shortage | 2024-06-11 | 2024-06-12 | 230095 |
TRIESENCE | 40MG | SUSPENSION | Resolved | 2018-10-23 | 2018-11-07 | 65471 |
TRIESENCE | 40MG | SUSPENSION | Resolved | 2019-01-25 | 2019-03-13 | 73545 |
TRIESENCE | 40MG | SUSPENSION | Resolved | 2019-05-07 | 2020-09-08 | 83368 |
TRIESENCE | 40MG | SUSPENSION | Resolved | 2021-06-04 | 2022-01-04 | 140457 |
TRIESENCE | 40MG | SUSPENSION | Actual shortage | 2022-03-30 | 2024-03-21 | 157590 |
TRILEPTAL 300 MG | 300MG | TABLET | Resolved | 2019-02-25 | 2019-03-07 | 76783 |
TRILEPTAL 300 MG | 300MG | TABLET | Resolved | 2020-11-09 | 2020-12-04 | 128180 |
TRILEPTAL 300 MG | 300MG | TABLET | Resolved | 2022-11-22 | 2023-04-13 | 175426 |
TRILEPTAL 600 MG | 600MG | TABLET | Resolved | 2020-11-09 | 2020-11-20 | 128183 |
TRILEPTAL 600 MG | 600MG | TABLET | Avoided shortage | 2020-11-23 | 2020-12-04 | 128738 |
TRILEPTAL 600 MG | 600MG | TABLET | Resolved | 2022-11-22 | 2023-04-13 | 175429 |
VIGAMOX | 0.5% | SOLUTION | Resolved | 2019-01-16 | 2019-03-26 | 72680 |
VOLTAREN | 50MG | SUPPOSITORY | Resolved | 2020-09-08 | 2020-10-19 | 123884 |
VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2017-11-30 | 2018-01-18 | 31276 |
VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2018-03-26 | 2018-12-11 | 44015 |
VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2018-03-26 | 2018-06-22 | 44018 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TRANSDERM-NITRO 0.6 | 0.6MG | PATCH (EXTENDED RELEASE) | Discontinued | 2021-05-05 | 2022-01-17 | 138767 |
VOLTAREN | 50MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-01-08 | 2020-03-10 | 102699 |
VOLTAREN OPHTHA | 0.1% | SOLUTION | Discontinued | 2019-09-11 | 2019-11-07 | 93561 |
VOLTAREN SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-04-02 | 2019-09-11 | 80298 |
VOLTAREN SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-07-10 | 2019-09-06 | 89039 |
VOLTAREN | 100MG | SUPPOSITORY | Discontinued | 2017-05-01 | 2017-11-02 | 8504 |
ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-05-05 | 123894 |
ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-09-23 | 123900 |
ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |